ESC 365 - Empagliflozin in a real-world chronic heart failure population

ESC Premium Access

Empagliflozin in a real-world chronic heart failure population

Session: Glucose abnormalities and left ventricular dysfunction

Topic: Pharmacotherapy

Speaker: Doctor G. Lopes da Cunha (Lisbon, PT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Goncalo Jose Lopes da Cunha

Hospital Santa Cruz, Lisbon (Portugal)

1 follower

6 more presentations in this session

The impact of diabetes mellitus on global longitudinal strain of patients with acute heart failure

Speaker: Doctor S. Kwak (Seoul, KR)

Reduced healthcare utilization in routine care initiators of empagliflozin with and without heart failure: interim analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Speaker: Doctor E. Patorno (Boston, US)

Peripheral neuropathy and increased risk of heart failure: a population-based longitudinal cohort study

Speaker: Professor C. Lang (Dundee, GB)

Diagnostic and prognostic utilities of insulin-like growth factor-binding protein-7 in patients presenting to the emergency department with dyspnea: results from the ICON-RELOADED study

Speaker: Doctor N. Ibrahim (Boston, US)

Metformin reduces the risk of hospitalization for heart failure in type 2 diabetes patients: a retrospective cohort analysis

Speaker: Doctor C. Tseng (Taipei, TW)

Access the full session

Glucose abnormalities and left ventricular dysfunction

Speakers: Doctor G. Lopes da Cunha, Doctor S. Kwak, Doctor E. Patorno, Professor C. Lang, Doctor N. Ibrahim...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources